Author

M. L. Poon

Observed name: Michelle Poon

Institutions: National University Cancer Institute, Singapore, National University Hospital

Observed institutions: National University Cancer Institute, Singapore, National University Hospital, National University Health System

OpenAlex ID: A5033513398

Subcutaneous Epcoritamab Induces Deep, Durable Complete Remissions in Relapsed/refractory Large B‐cell Lymphoma: Longer Follow‐up From the Pivotal Epcore Nhl‐1 Trial

2023 · C. Thieblemont, Y. Karimi, et al. · Hematological Oncology · 7

Pulmonary AL Amyloidosis as a Cause of Interstitial Lung Disease Diagnosed With Transbronchial Lung Biopsy

2026 · Kai Wen Hwang, Ju Ee Seet, et al. · Respirology Case Reports

Donor and stem cell source selection in hematopoietic cell transplantation in the Asia-Pacific region: results from the APBMT Activity Survey 2022-2023.

2026 · Minako Iida, Xiao Jun Huang, et al. · PubMed

Odronextamab in people with relapsed or refractory follicular lymphoma: plain language summary of the ELM-2 study

2026 · Jose C. Villasboas, Michelle Poon, et al. · Future Oncology

673 | Prognostic Factors and Outcomes in Patients With Late Relapse Diffuse Large B‐cell Lymphoma Treated With Second‐line Chemotherapy and Autologous Stem Cell Transplantation

2025 · J. Y. Tan, V. W. T. Ling, et al. · Hematological Oncology

204 | AN EXPLAINABLE ARTIFICIAL INTELLIGENCE mDELRelapseNet MODEL TO PREDICT RELAPSE IN DIFFUSE LARGE B‐CELL LYMPHOMA BASED ON THE SPATIAL ORGANIZATION OF MYC+BCL2+BCL6− Cells

2025 · S. Sridhar, K. Gupta, et al. · Hematological Oncology

Angioimmunoblastic T cell lymphoma prognostic index in Asian population identifies low risk patients with unique gene expression profiles

2023 · E. W. Y. Chang, V. S. Yang, et al. · Hematological Oncology

Works count: 7

Citation count: 7

H-index: 1

I10-index: